Regeneron Pharmaceuticals (REGN)
Capital Expenditure
-$920.90M
TTM · Period ending: · USD
REGN Capital Expenditure
Latest reported-$920.90Mperiod ending
Latest reported-$920.90Mperiod ending
REGN TTM CapEx (-$2.10M → -$920.90M)
TTM CapEx
High-resolution chart · PNG
REGN capital expenditure history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -6,062,000 | |
| -6,367,000 | |
| -6,495,000 | |
| -6,130,000 | |
| -6,289,000 | |
| -6,471,000 | |
| -5,700,000 | |
| -5,500,000 | |
| -5,600,000 | |
| -3,100,000 | |
| -3,000,000 | |
| -3,000,000 | |
| -2,100,000 | |
| -1,800,000 | |
| -2,100,000 | |
| -2,100,000 | |
| -2,200,000 | |
| -5,000,000 | |
| -8,600,000 | |
| -10,700,000 | |
| -10,600,000 | |
| -8,000,000 | |
| -3,300,000 | |
| -100,000 | |
| -400,000 | |
| -1,500,000 | |
| -6,900,000 | |
| -15,500,000 | |
| -16,000,000 | |
| -15,500,000 | |
| -10,200,000 | |
| 47,800,000 | |
| -1,800,000 | |
| -1,800,000 | |
| -2,100,000 | |
| -52,800,000 | |
| -2,100,000 |